Olympus Corporation - ADR (OLYMY)
OTC PINK OTC PINK Primary 
XFRA Summary
OLYMY Chart
People also search for
Olympus Corporation - ADR Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Peter Sigismondi Ramirez Asset Management, Inc. | 1,590 | $20,707.03 | $16,504.2 | -$4,202.83 | -20.3% |
Olympus Corporation - ADR (OLYMY) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Olympus Corporation - ADR ever had a stock split?
Olympus Corporation - ADR Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Frank Drewalowski CEO | OTC PINK Exchange | 320120000 CUSIP |
| JP Country | 29,297 Employees | 31 Mar 2025 Last Dividend | 9 Apr 2019 Last Split | - IPO Date |
Overview
Olympus Corporation, originally known as Olympus Optical Co., Ltd., is a global leader in the manufacturing and sale of precision machinery and instruments. The company has a rich history that dates back to its inception in 1919 and has its headquarters situated in Tokyo, Japan. Over the years, Olympus Corporation has undergone significant transformations, including a name change in October 2003, to better reflect its diversified product range and global presence. Olympus operates through four main business segments: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and Others. Each of these segments is geared towards providing innovative solutions in their respective fields, contributing to Olympus's reputation as a pioneer in medical and scientific equipment.
Products and Services
- Endoscopic Solutions Business
This segment delivers a comprehensive array of gastrointestinal and surgical endoscopy systems alongside surgical microscopes. Olympus also offers endoscope reprocessors and maintenance services, ensuring the durability and reliability of its endoscopic products. The focus here is on enhancing the efficiency of medical procedures and improving patient outcomes through state-of-the-art imaging and minimally invasive techniques.
- Therapeutic Solutions Business
Olympus's offering in this domain includes a variety of products for urology, gynecology, respiratory care, as well as ear, nose, and throat (ENT) treatments. The segment is particularly noted for its GI endo-therapy devices, energy devices, and surgical single-use devices, which are designed to facilitate complex therapeutic procedures with precision and care.
- Scientific Solutions Business
This segment caters to the needs of the scientific community, providing biological and industrial microscopes, industrial videoscopes, and non-destructive testing equipment. Additionally, Olympus supplies X-ray fluorescence (XRF) analyzers, instruments key in material analysis across various industries. The focus here is on delivering precision, enhancing research capabilities, and contributing to the advancement of science and industry.
- Others
Under this segment, Olympus develops and supplies biomedical materials such as synthetic bone fillers and orthopedic equipment. These products are a testament to Olympus’s commitment to extending its technological expertise beyond traditional boundaries and meeting the diverse needs of its global clientele.
